27 Jun Date June 27, 2024 Author TelaraPharma Tags Arch Biopartners, The Cilastatin project Arch Biopartners Announces GMP Manufacturing of Cilastatin Drug Product TORONTO, June 27, 2024 (GLOBE NEWSWIRE) — Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and O...